Atrility Medical key facts
- Developer of a cardiac monitoring device designed for the diagnosis of atrial arrhythmia.
- It has raised $5.0M across 4 recorded rounds; the latest was Seed Round ($1.0M) in Nov 2025.
- Notable investors include Wisconsin Economic Development, WARF Ventures, Discovery to Product, Rock River Capital Partners, Southwest National Pediatric Device Innovation Consortium — 7 tracked in total.
- Atrility Medical has filed 3 Form Ds with the SEC since 2018, most recently Jun 2022 ($3.4M sold to 15 investors).
- Status: Privately Held (backing).
- ·Watch Atrility Medical: the Monday email on marks, rounds and moves
Atrility Medical funding rounds
4 roundsHow much has Atrility Medical raised?
Atrility Medical has raised $5 million across 4 recorded rounds since 2018. The largest was a $3.4 million seed round in Jun 2022; the most recent was a $1 million seed round in Nov 2025.
Atrility Medical has filed 3 Form Ds with the SEC since 2018, most recently in Jun 2022 ($3.4 million sold to 15 investors).
Atrility Medical investors
7 investors are on record for Atrility Medical, including Wisconsin Economic Development, WARF Ventures, Discovery to Product and Rock River Capital Partners. The seed round in Nov 2025 drew 3 investors.
About Atrility Medical
Developer of a cardiac monitoring device designed for the diagnosis of atrial arrhythmia. The company's device facilitates the monitoring and treatment of atrial arrhythmias by providing a continuous atrial electrogram and aims to bring cardiac medical devices to market by closely integrating healthcare, business, and engineering specialists, enabling healthcare providers to improve patient outcomes.
- Sector
- Healthcare
- HQ
- Madison, WI, United States
- Founded
- 2017
- Employees
- 10
- Website
- atrility.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Atrility Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.